Pivotal Therapeutics Inc. announced earnings results for the nine months ended September 30, 2015. For the period, the company reported an increase in sales of 88% to CAD 373,787 from CAD 198,867 in 2014. The company reported a decrease of 32% in net loss to CAD 3,706,876 from CAD 5,418,497 in 2014.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0018 USD | +179,900.00% |
|
-.--% | -.--% |
2016 | Pivotal Therapeutics Inc. Announces Management Changes | CI |
2015 | Ford Teams with Pivotal to Speed Development of Connected Car Experiences Capitalizing on New Ford Sync Connect | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 172K | |
+20.70% | 43.77B | |
+30.16% | 22.83B | |
+18.68% | 14.34B | |
+54.86% | 12.96B | |
-0.05% | 6.79B | |
-11.72% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B | |
+9.49% | 4.75B |
- Stock Market
- Equities
- PVTTF Stock
- News Pivotal Therapeutics Inc.
- Pivotal Therapeutics Inc. Announces Earnings Results for the Nine Months Ended September 30, 2015